BLENDS / BLEND
WOLVERINE STACK
10MG · 20MGThis content is intended for educational and research reference only and does not constitute medical advice, diagnosis, or treatment. Experimental compounds are for research use only and are not for human consumption. Always consult qualified healthcare providers before starting any therapy.
Research Overview
A 1:1 research blend combining BPC-157 and TB-500, studied together across tissue-repair and recovery-pathway research.
Available Strengths
- 10MG (BB10)
- 20MG (BB20)
Research Protocol
Reference standard schedule (combined daily dose)
| Period | Dose | U-100 units | Volume |
|---|---|---|---|
| Weeks 1–2 (initial) | 0.6 mg | 18 | 0.18 mL |
| Weeks 3–4 (loading) | 0.8 mg | 24 | 0.24 mL |
| Weeks 5–8+ (maintenance) | 0.6 mg | 18 | 0.18 mL |
Reconstitution
≈3.33 mg/mL combined (≈1.67 mg/mL each compound)
- Draw 3.0 mL of bacteriostatic water per 10 mg vial.
- Inject slowly along the vial wall; swirl gently until dissolved.
Research context
Component research discusses BPC-157 in nitric-oxide and growth-factor pathways and TB-500 as an actin-sequestering peptide supporting cell migration; component findings do not establish the combined vial's own safety or efficacy.
Storage
−20°C, dry and dark. 2–8°C, use within 4–6 weeks, avoid freeze-thaw cycles.
Research Notes
- For educational and research reference only. Not medical advice and not intended for unsupervised human use.
- No approved human protocol exists for this proprietary combination.
References
Source reference: PeptideDosages.com · 2026-08-18 · Exact strength match with the cited source